Biotest AG
Biotest AG: Biotest successfully enters China, the world’s biggest Human Albumin market
DGAP-News: Biotest AG
/ Key word(s): Market launch
PRESS RELEASE Biotest successfully enters China, the world’s biggest Human Albumin market – First sales of Human Albumin in China – Access to the largest Human Albumin market with more than 450 tonnes per year representing a market value of about € 2.5 billion – Chinese market has double-digit growth rates every year
Human Albumin is used for stabilisation of blood circulation in severe diseases such as burns as well as chronic diseases of the liver and kidneys or complications associated with protein loss. China represents not only the biggest Human Albumin market in the world in terms of volume with more than 450 tonnes per year but also the biggest in terms of value with a market value of about € 2.5 billion. In addition, the annual consumption has been growing with double-digit numbers during the last years. “China and the Asia Pacific region as a whole represent the main pillars of Biotest international expansion. We are very proud to enter successfully in a market with many opportunities. Together with our partner we have worked successfully with the Chinese authorities despite the difficult COVID-19 situation and proved to be a reliable and energetic partner for all our stakeholders” commented Giuliano Tagliabue, Vice President Region Intercontinental. About Human Albumin Albumin is commercialized in Germany under the brand name “Albiomin” and in China marketed as “Human Albumin Injection”. About Biotest IR contact PR contact Ordinary shares: securities’ ID No. 522720; ISIN DE0005227201 Disclaimer
10.06.2020 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG. |
Language: | English |
Company: | Biotest AG |
Landsteinerstraße 5 | |
63303 Dreieich | |
Germany | |
Phone: | 0 61 03 – 8 01-0 |
Fax: | 0 61 03 – 8 01-150 |
E-mail: | investor_relations@biotest.de |
Internet: | http://www.biotest.de |
ISIN: | DE0005227235, DE0005227201 |
WKN: | 522723, 522720 |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1066161 |
End of News | DGAP News Service |